11479952

Wu J

1999

[Insulin resistance in patients with polycystic ovary syndrome].

11480095

Mercurio MG

2001

Hirsutism: diagnosis and management.

11497481

Bloomgarden ZT

2001

Use of insulin-sensitizing agents in patients with polycystic ovary syndrome.

11502783

Ib??ez L

2001

Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.

11502810

Veldhuis JD

2001

Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.

11506853

Cheung AP

2001

Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome.

11508781

Fulghesu AM

2001

Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study.

11509861

Toprak S

2001

Insulin resistance in nonobese patients with polycystic ovary syndrome.

11511859

Rosenfield RL

2001

Polycystic ovary syndrome and insulin-resistant hyperinsulinemia.

11514331

Duleba AJ

2001

Activin stimulates proliferation of rat ovarian thecal-interstitial cells.

11515833

Seidenfeld ME

2001

Impact of anorexia, bulimia and obesity on the gynecologic health of adolescents.

11517008

Cagnacci A

2001

Insulin sensitivity in women: a comparison among values derived from intravenous glucose tolerance tests with different sampling frequency, oral glucose tolerance test or fasting.

11517009

Pirwany IR

2001

Circulating leptin concentrations and ovarian function in polycystic ovary syndrome.

11520327

Duncan S

2001

Polycystic ovarian syndrome in women with epilepsy: a review.

11522279

Sabuncu T

2001

Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease.

11522686

El Mkadem SA

2001

Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome.

11524214

Glueck CJ

2001

Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).

11524244

Pehlivan T

2001

Effects of transforming growth factors-alpha and -beta on proliferation and apoptosis of rat theca-interstitial cells.

11524801

Isoj?rvi J

1998

[The dangers of valproate in women].

11527889

Keay SD

2001

Low-dose dexamethasone augments the ovarian response to exogenous gonadotrophins leading to a reduction in cycle cancellation rate in a standard IVF programme.

11527911

Norman RJ

2001

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

11529405

Tat? L

2001

Optimal therapy of pubertal disorders in precocious/early puberty.

11530127

Douchi T

2001

Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome.

11531609

Tan WC

2001

Clinical management of PCOS.

11531925

Marsden PJ

2001

Tissue insulin sensitivity and body weight in polycystic ovary syndrome.

11532473

Luboshitzky R

2001

Increased 6-sulfatoxymelatonin excretion in women with polycystic ovary syndrome.

11532474

Yarali H

2001

Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome.

11543750

Park KH

2001

Polycystic ovarian syndrome (PCOS) and insulin resistance.

11543751

Alborzi S

2001

Ovarian size and response to laparoscopic ovarian electro-cauterization in polycystic ovarian disease.

11543854

Gogacz M

2001

Peritoneal fluid leptin concentration in infertile patients.

11543855

Reimand K

2001

Autoantibody studies of female patients with reproductive failure.

11545683

Sills ES

2001

Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports.

11549651

Fujiwara T

2001

Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles.

11552437

Ben?tez R

2001

[Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome].

11552451

Sir-Petermann T

2001

[Polycystic ovary syndrome: the importance of establishing diagnosis].

11552458

Morales Gonz?lez JA

2001

[Transforming growth factor alpha (TGF-alpha) and epidermoid growth factor (EGF) in polycystic ovary syndrome: potential role in the decrease of apoptosis mechanisms in the follicle].

11554885

Stephen LJ

2001

Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.

11561739

Batukan C

2001

Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome.

11561833

Sills ES

2001

Plasma homocysteine, fasting insulin, and androgen patterns among women with polycystic ovaries and infertility.

11566460

Isoj?rvi JI

2001

Altered ovarian function and cardiovascular risk factors in valproate-treated women.

11568818

Sherwin R

2001

PCOS and OCPs?

11569168

Sindelka G

2001

[Can hormonal contraceptives affect plasma levels of IGF-1 and IGFBP-1 in slim women with polycystic ovary syndrome?].

11570966

Mikkelsen AL

2001

Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and the outcome: a randomized prospective study.

11574492

Greisen S

2001

Effects of androstenedione, insulin and luteinizing hormone on steroidogenesis in human granulosa luteal cells.

11574493

Ciotta L

2001

Clinical, endocrine and metabolic effects of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance.

11574494

L?d?e-Bataille N

2001

Follicular fluid concentration of leukaemia inhibitory factor is decreased among women with polycystic ovarian syndrome during assisted reproduction cycles.

11574495

G?kyar D

2001

Basal and day 12 inhibin concentrations in the prediction of ovarian response to gonadotrophins in women with PCOS.

11588809

Ayala AR

2001

[Insulin resistance index: measurement and potential in human reproduction].

11591271

Nasseri S

2001

Clomiphene citrate in the twenty-first century.

11591406

Hines GA

2001

Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: preliminary studies.

11591418

Ferraretti AP

2001

Transvaginal ovarian drilling: a new surgical treatment for improving the clinical outcome of assisted reproductive technologies in patients with polycystic ovary syndrome.

11591425

Clyde JM

2001

Demonstration of a mechanism of aneuploidy in human oocytes using Multifluor fluorescence in situ hybridization.

11592266

Jagasia SM

2001

Visual vignette: acanthosis nigricans.

11594673

Stein RH

2001

Acne therapy: clinical pearls.

11595813

Orfanos CE

2000

The SAHA syndrome.

11595827

Pugeat M

2000

Association of insulin resistance with hyperandrogenia in women.

11596679

Sir-Petermann T

2001

G972R polymorphism of IRS-1 in women with polycystic ovary syndrome.

11597313

Mikkelsen AL

2001

Incidence of apoptosis in granulosa cells from immature human follicles.

11597618

Parsanezhad ME

2001

Insulin resistance in clomiphene responders and non-responders with polycystic ovarian disease and therapeutic effects of metformin.

11598355

Resende AV

2001

Doppler study of the uterine arteries and ovarian stroma in patients with polycystic ovary syndrome.

11599250

Radwan J

2001

[The effects of micro-laparoscopic ovarian electrocautery as a method of polycystic ovary syndrome treatment].

11599464

Ajossa S

2001

Uterine perfusion and hormonal pattern in patients with polycystic ovary syndrome.

11600523

Diamanti-Kandarakis E

2001

Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.

11600562

Oltmanns KM

2001

Hypoglycemia, but not insulin, acutely decreases LH and T secretion in men.

11600596

Landman RE

2001

Troglitazone use in polycystic ovary syndrome.

11604203

Guvenal T

2001

Unilateral massive ovarian edema in a woman with polycystic ovaries.

11604221

Marshall JC

2001

Hypothalamic dysfunction.

11675158

Wong E

2001

Problems of HRQL assessment: how much is too much?

11677329

Kriplani A

2001

Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome.

11678578

Dincer Y

2001

Effect of sex hormones on lipid peroxidation in women with polycystic ovary syndrome, healthy women, and men.

11678825

Michelmore K

2001

Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight.

11679501

Papaleo E

2001

Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome.

11680438

Corleta H

2001

Why can't a man be more like a mouse?

11680439

McDonough PG

2001

Why can't a man be more like a mouse?

11684113

Weerakiet S

2001

Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome.

11687100

Farquhar C

2001

Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.

11694344

Legro RS

2001

Polycystic ovary syndrome: the new millenium.

11701699

Ciampelli M

2001

Metabolic and endocrine consequences of acute suppression of FFAs by acipimox in polycystic ovary syndrome.

11702316

Falsetti L

2000

Management of hirsutism.

11702849

Janeckova R

2001

The role of leptin in human physiology and pathophysiology.

11703206

Ramzy AM

2001

Ultrasonographic guided ovarian stroma hydrocoagulation for ovarian stimulation in polycystic ovary syndrome.

11704114

Child TJ

2001

In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome.

11704136

Cataldo NA

2001

Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone.

11705066

Anate M

2001

Anovulatory infertility: a report of four cases and literature review.

11710164

Couzin J

2001

Focus on your health. 'It's not your fault'.

11716155

Speiser PW

2001

Congenital adrenal hyperplasia: transition from chil dhood to adulthood.

11719591

L?ffler S

2001

Evidence of leptin expression in normal and polycystic human ovaries.

11719715

Barber D

2001

Partnerships in women's health: RCN Gynaecological Nurses' Forum and Fertility Nurse Group.

11719720

Rjosk HK

2001

Preliminary experience with steroidal ovarian suppression for prevention of severe ovarian hyperstimulation syndrome in IVF patients.

11720200

Maitra A

2001

Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: a study among Indian women.

11720881

Escobar-Morreale HF

2001

Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies.

11720900

Bili H

2001

Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years.

11723711

Martin-Du Pan R

2001

[The benefits of aging. I. Patience and cure: spontaneous beneficial course of certain diseases].

11726572

Koivunen RM

2001

Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.

11726573

Eldar-Geva T

2001

Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.

11726582

Wang JX

2001

Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment.

11727360

Nardo LG

2001

Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects.

11727361

Zarkovi? M

2001

Temporal coupling of luteinizing hormone and follicle stimulating hormone secretion in polycystic ovary syndrome.

11727859

Balen A

2001

Polycystic ovary syndrome and cancer.

11728659

Yildiz BO

2001

Insulin resistance in polycystic ovary syndrome: hyperandrogenemia versus normoandrogenemia.